World Video | Defence | Foreign Affairs | Natural Events | Trade | NZ in World News | NZ National News Video | NZ Regional News | Search

 


Testing for Counterfeit Drug Tool Screening Begins in Africa

Field Testing for Rapid Counterfeit Drug Screening Tool Begins in Africa

Initial testing targets ability to identify fake & poor quality malaria medicines

Rockville, Md., June 4, 2014 — Field testing for a new screening tool intended to help quickly detect counterfeit and poor quality medicines has begun at the U.S. Pharmacopeial Convention’s (USP) Center for Pharmaceutical Advancement and Training (CePAT), located in Ghana.

The new screening device, called CD-3+, was launched by the U.S. Food and Drug Administration in April 2013.

“CD-3+ is, rapid, portable device that requires little training for effective use, potentially changing the way counterfeit and poor quality products are detected and resulting in substantial cost savings over more expensive alternatives,” says Patrick Lukulay, Ph.D., vice president of Global Health Impact Programs at USP and director of the Promoting the Quality of Medicines program (PQM). “The testing now underway in Ghana will provide a side-by-side comparison of CD-3+ with other existing screening devices to assess the capability to discriminate between authentic and substandard medicines.”

Specifically, the tests conducted in the field and at CePAT will evaluate CD-3+ in the screening of two malaria treatments commonly used in Sub-Saharan Africa. A total of 200 test samples are being collected from sites across Ghana through acollaborative partnership between USP and the Ghana’s Food and Drug Authority. Results from the first field study are expected in September 2014.

“Field tests such as these will not only help us determine complementary advantages of the tools under evaluation, but will also help identify potential design improvements to CD-3+ to enable the development of a more robust, more portable and even easier to use tool,” says Leigh Verbois, director, Asia Pacific Office, Office of International Programs at U.S. FDA.

The U.S. FDA was responsible for training personnel on how to properly use CD-3+ at CePAT and other test sites.

Testing is being conducted under an agreement between FDA and the U.S. Agency for International Development (USAID), which funds PQM, operated by USP. Funding for the activity has been provided by the Skoll Global Threats Fund. Other partners include the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC).

“As a development agency, USAID is well-positioned for in-country capacity building such as this,” says Anthony Boni, who leads PQM on USAID’s side through its Office of Health Systems in the Bureau for Global Health. “The presence of infrastructure as well as established relationships with the Ghana FDA provided an excellent platform for the field-testing of CD-3+ in Ghana.”

Since 2008, USAID, through the U.S. President’s Malaria Initiative (PMI) Ghana, has provided USP with US$1,470,000, specifically to strengthen the capacity of the Ghana FDA for the quality assurance of medicines in Ghana.

The tests being conducted in Ghana will evaluate CD-3+ in complementing GPHF’s Minilab™ (thin-layer chromatography) and Thermo Scientific’s TruScan™ (hand-held Raman spectrometer), evaluating counterfeit detection for two commonly used artemisinin-based combination therapies (ACTs) for malaria treatment in Sub-Saharan Africa: artemether + lumefantrine (AR-LU) and artesunate + amodiaquine (AS-AQ).

ENDS

© Scoop Media

 
 
 
 
 
World Headlines

 

Palestinian Refugees From Syria Face Worsening Situation

Palestinian women at a UNRWA distribution centre in the Jaramana refugee camp, Damascus, Syria. Photo: UNRWA/Carole Alfarah More>>

ALSO:

Greece Risks Prolonged Social Crisis

Greece’s severe financial crisis has bred social unrest and intolerance of the nearly one million irregular migrants living in the country (October 2012). Photo: IRIN/Kristy Siegfried More>>

Madagascar: Warning Of ‘rapid’ Spread Of Plague In Capital

Ny Hantra Andriatsifasoa survived the bubonic plague after being infected in Madagascar in 2011. Photo: IRIN/Tiana Randriaharimalala More>>

New Bird Flu Strain In Europe Threatens Poultry Sector

24 November 2014 – The United Nations Food and Agriculture Organization ( FAO ) today warned that a new bird flu strain detected in Europe poses a significant threat to the poultry sector, especially in low-resourced countries situated along ... More>>

Mexico: Disappearances Reach Record Number This Year

The National Registry of Missing Persons acknowledges that from 2007 to date, there are 23,605 cases of disappeared persons; 40% have been reported during the current administration of President Enrique Peña Nieto. More>>

Ban To Take Up Fight Against Ebola With All UN Organisations

Street sellers at Waterside market in central Monrovia, where there has seen a huge drop in customers over the past months due to the onset of the Ebola Virus Disease. Photo: UNDP/Carly Learson (20 November 2014) More>>

ALSO:

Darfur: UN-Backed Event Promotes Role Of Women In Peace

Darfur: amid mass rape allegations, UN-backed event promotes role of women in peace processes More>>

Ebola Cases No Longer Rising In Guinea And Liberia

In Conakry, Guinea, a mobilizer teaches children about proper handwashing techniques, which help prevent the spread of diseases, including Ebola. Photo: UNICEF/Timothy La Rose More>>

ALSO:


Get More From Scoop

 
 
 
 
 
World
Search Scoop  
 
 
Powered by Vodafone
NZ independent news